Article info
Aetiology
Systematic review and meta-analysis
Need for standardising adverse event reporting in testosterone trials
- Correspondence to: Dr Shehzad Basaria, Section on Men's Health, Aging and Metabolism, Brigham & Women's Hospital, 221 Longwood Avenue, 5th Floor, Boston, MA 02115, USA; sbasaria{at}partners.org
Citation
Need for standardising adverse event reporting in testosterone trials
Publication history
- First published July 17, 2013.
Online issue publication
March 08, 2024
Article Versions
- Previous version (8 March 2024).
- Previous version (8 March 2024).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions